167 related articles for article (PubMed ID: 36139597)
1. Pan-Cancer Analysis of Pentraxin 3: A Potential Biomarker of COVID-19.
Zhou Z; Zhou X; Yang Y; Wang L; Wu Z
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139597
[TBL] [Abstract][Full Text] [Related]
2. Pan-cancer analysis reveals the prognostic gene CASR suppresses tumor progression and epithelial-mesenchymal transition in renal clear cell carcinoma.
Zhou Z; Feng D; Yang Y; Gao P; Wang L; Wu Z
Cell Calcium; 2023 Dec; 116():102803. PubMed ID: 37804688
[TBL] [Abstract][Full Text] [Related]
3. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
4. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
5. Clinical Utility of Circulating Pentraxin 3 as a Prognostic Biomarker in Coronavirus Disease 2019: A Systematic Review and Meta-analysis.
Ke Y; Wu K; Shen C; Zhu Y; Xu C; Li Q; Hu J; Liu S
Infect Dis Ther; 2023 Jan; 12(1):67-80. PubMed ID: 36443545
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of MFN2 as a prognostic biomarker associated with immune cell infiltration in renal clear cell carcinoma.
Cheng L; Wang Z; Nie L; Yang C; Huang H; Lin J; Zhuo D
Int Immunopharmacol; 2022 Oct; 111():109169. PubMed ID: 36007389
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic role of basic leucine zipper transcription factor in kidney renal clear cell carcinoma.
Zhang H; Zhang H; Hu Y; Huang B; Chen J; Chen L
Transl Androl Urol; 2022 Feb; 11(2):238-252. PubMed ID: 35280662
[TBL] [Abstract][Full Text] [Related]
8. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
Sun K; Chen RX; Li JZ; Luo ZX
Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
[TBL] [Abstract][Full Text] [Related]
9. Sperm Autoantigenic Protein 17 Predicts the Prognosis and the Immunotherapy Response of Cancers: A Pan-Cancer Analysis.
Tu Z; Peng J; Long X; Li J; Wu L; Huang K; Zhu X
Front Immunol; 2022; 13():844736. PubMed ID: 35592314
[TBL] [Abstract][Full Text] [Related]
10. Pan-Cancer Analysis of the N6-Methyladenosine Eraser FTO as a Potential Prognostic and Immunological Biomarker.
Zhao C; Liu Y; Ju S; Wang X
Int J Gen Med; 2021; 14():7411-7422. PubMed ID: 34744452
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analyses of PDHA1 that serves as a predictive biomarker for immunotherapy response in cancer.
Deng L; Jiang A; Zeng H; Peng X; Song L
Front Pharmacol; 2022; 13():947372. PubMed ID: 36003495
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Pan-Cancer Analysis and the Regulatory Mechanism of ASF1B, a Gene Associated With Thyroid Cancer Prognosis in the Tumor Micro-Environment.
Ma J; Han W; Lu K
Front Oncol; 2021; 11():711756. PubMed ID: 34490109
[TBL] [Abstract][Full Text] [Related]
13. Pan-Cancer Analysis Identified CD93 as a Valuable Biomarker for Predicting Patient Prognosis and Immunotherapy Response.
Tong W; Wang G; Zhu L; Bai Y; Liu Z; Yang L; Wu H; Cui T; Zhang Y
Front Mol Biosci; 2021; 8():793445. PubMed ID: 35265666
[No Abstract] [Full Text] [Related]
14. A combined analysis of bulk and single-cell sequencing data reveals metabolic enzyme, pyruvate dehydrogenase E1 subunit beta (PDHB), as a prediction biomarker for the tumor immune response and immunotherapy.
Zhang F; Yan Y; Liang Q; Liu Y; Wu G; Xu Z; Yang K
Heliyon; 2023 Feb; 9(2):e13456. PubMed ID: 36816316
[TBL] [Abstract][Full Text] [Related]
15. Pan-cancer analysis of the prognostic and immunological role of BRCA1-associated protein 1 gene (BAP1): Friend or foe?
Wang T; Zhu T; Zhang Y; Bai J; Xue Y; Xu G; Lu L; Peng Q
Gene; 2022 Oct; 840():146765. PubMed ID: 35905855
[TBL] [Abstract][Full Text] [Related]
16. Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunction.
Song J; Yang R; Wei R; Du Y; He P; Liu X
Mol Med; 2022 May; 28(1):47. PubMed ID: 35508972
[TBL] [Abstract][Full Text] [Related]
17. A Pan-Cancer Analysis of the Oncogenic Role of
Yang D; Li H; Chen Y; Li C; Ren W; Huang Y
Front Genet; 2022; 13():906174. PubMed ID: 35910232
[No Abstract] [Full Text] [Related]
18. Comprehensive Landscape of RRM2 with Immune Infiltration in Pan-Cancer.
Zhou Z; Song Q; Yang Y; Wang L; Wu Z
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740608
[TBL] [Abstract][Full Text] [Related]
19. A Comprehensive Prognostic and Immune Analysis of SLC41A3 in Pan-Cancer.
Liu J; Zhang S; Dai W; Xie C; Li JC
Front Oncol; 2020; 10():586414. PubMed ID: 33520701
[TBL] [Abstract][Full Text] [Related]
20. Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas.
Wei C; Wang B; Peng D; Zhang X; Li Z; Luo L; He Y; Liang H; Du X; Li S; Zhang S; Zhang Z; Han L; Zhang J
Front Immunol; 2022; 13():849592. PubMed ID: 35444654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
